Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

Oral Oncology
Herbert RiechelmannSilke Gronau

Abstract

CD44v6 is a tumor associated antigen abundantly expressed in head and neck squamous cell carcinomas (HNSCC) and in normal squamous epithelium. The immunoconjugate bivatuzumab mertansine (BIWI 1) consists of a highly potent antimicrotubule agent coupled to a monoclonal antibody against CD44v6. The maximum tolerated dose (MTD), safety and efficacy of BIWI 1 administered IV in patients with HNSCC has not been determined. In a clinical phase I trial, adult patients with recurrent or metastatic HNSCC were treated intravenously with BIWI 1. Starting with 25mg/m(2), the dose was escalated in steps of 25mg/m(2) until dose limiting toxicity was observed. Six women and 25 men were included. The MTD was 300 mg/m(2). Twelve patients were treated with at least the MTD. The principal toxic effects were maculopapular rashes, focal blister formation and skin exfoliation. Three patients had partial responses at doses of 200, 275 and 325 mg/m(2). The concept that bivatuzumab can direct mertansine activity to CD44v6 expressing tumors was confirmed. Although CD44v6 was abundantly expressed in all tumors, the response to BIWI 1 was variable. Binding to CD44v6 on skin keratinocytes mediated serious skin toxicity with a fatal outcome in a parallel tr...Continue Reading

References

Aug 6, 1997·Journal of the National Cancer Institute·R SimonM C Christian
Jun 6, 2000·Advanced Drug Delivery Reviews·R V Chari
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony W TolcherEric K Rowinsky
Feb 6, 2004·Cancer Immunology, Immunotherapy : CII·Karl-Heinz HeiderGerd Munzert
Mar 6, 2004·Pharmacological Reviews·Martijn RooseboomNico P E Vermeulen
Nov 4, 2004·JAMA : the Journal of the American Medical Association·Thomas G RobertsJeffrey W Clark
Mar 29, 2006·Journal of Burn Care & Research : Official Publication of the American Burn Association·Agnes OplatekRichard L Gamelli
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Dimitrios Colevas
Jul 11, 2006·Journal of Medicinal Chemistry·Wayne C WiddisonRavi V J Chari
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bernard M TijinkGuus A M S van Dongen

❮ Previous
Next ❯

Citations

Jul 9, 2013·Leukemia Research·Dayle A DainesRobert J McKallip
Feb 16, 2010·Current Opinion in Oncology·Pol Specenier, Jan B Vermorken
Oct 18, 2013·Science Translational Medicine·Luc R DesnoyersHenry B Lowman
Aug 30, 2012·Haematologica·Valentina HoyosGianpietro Dotti
Mar 1, 2011·Therapeutic Delivery·Victor S Goldmacher, Yelena V Kovtun
Nov 29, 2013·International Journal of Cell Biology·Serena BonomiClaudia Ghigna
Jan 25, 2014·Cell Death & Disease·Y SuhM Tavassoli
Aug 2, 2013·Rejuvenation Research·Anastasia V ShindyapinaAlexander Zhavoronkov
Sep 17, 2015·Expert Opinion on Therapeutic Targets·Ibrahim H Sahin, Jim Klostergaard
May 25, 2012·Expert Opinion on Therapeutic Targets·Sukhen C GhoshJim Klostergaard
Aug 8, 2012·The Journal of Cell Biology·Irène Baccelli, Andreas Trumpp
Oct 11, 2015·Journal of Drug Targeting·George MattheolabakisMansoor M Amiji
Nov 26, 2015·Advanced Drug Delivery Reviews·Franco DosioElias Fattal
Jan 31, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Victor FattoriWaldiceu A Verri
Dec 27, 2011·Cancer Treatment Reviews·Giuditta Mannelli, Oreste Gallo
Aug 17, 2011·Journal of Pharmacological and Toxicological Methods·U Iyer, V J Kadambi
Apr 23, 2011·Critical Reviews in Oncology/hematology·Andreas E AlbersAndreas M Kaufmann
Jun 29, 2010·Critical Reviews in Oncology/hematology·J Loeffler-RaggR Stauder
Apr 27, 2010·Seminars in Cancer Biology·Ben-Zion Katz
Mar 23, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Véronique Orian-Rousseau
Nov 1, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Leila ArabiMahmoud Reza Jaafari
Jan 30, 2015·Clinical and Translational Medicine·Christian A GravesLucia Pirisi
Oct 9, 2015·International Journal of Cell Biology·Suniti MisraShibnath Ghatak
Dec 5, 2014·Archives of Toxicology·V Orian-Rousseau, H Ponta
Jun 16, 2016·Scientific Reports·Jiefu JinZaver M Bhujwalla
Sep 6, 2012·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·S BüngerJ K Habermann
Mar 25, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Benoit LouageBruno G De Geest
Feb 2, 2018·Journal of Applied Toxicology : JAT·Sarah TaplinRobert Johnson
Sep 27, 2014·World Journal of Stem Cells·Christen L Walters HaygoodDonald J Buchsbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.